Symbol="OCGN"
AssetType="Common Stock"
Name="Ocugen Inc"
Description="Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the development of gene therapies to cure diseases of blindness. The company is headquartered in Malvern, Pennsylvania."
CIK="1372299"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="5 GREAT VALLEY PARKWAY, SUITE 160, MALVERN, PA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="128446000"
EBITDA="-84007000"
PERatio="None"
PEGRatio="None"
BookValue="0.335"
DividendPerShare="0"
DividendYield="0"
EPS="-0.34"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.444"
ReturnOnEquityTTM="-0.772"
RevenueTTM="-380"
GrossProfitTTM="-49757000"
DilutedEPSTTM="-0.34"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="3.9"
TrailingPE="-"
ForwardPE="15.22"
PriceToSalesRatioTTM="25069.32"
PriceToBookRatio="3.652"
EVToRevenue="35591.28"
EVToEBITDA="-3.362"
Beta="3.627"
num_52WeekHigh="2.935"
num_52WeekLow="0.44"
num_50DayMovingAverage="0.541"
num_200DayMovingAverage="0.975"
SharesOutstanding="256430000"
DividendDate="2019-09-30"
ExDividendDate="None"
symbol="OCGN"
open="0.50"
high="0.50"
low="0.48"
price="0.50"
volume="2046093.00"
latest_trading_day="2023-08-11"
previous_close="0.50"
change="0.00"
change_percent="0.5016%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="100"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="0"
Volume_recent_avg="6614108"
Change_recent_avg="-0.01"
Delta_recent_avg="0.04"
Variance_recent_avg="0.02"
Change_ratio_recent_avg="-1.21"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="0"
Aroon_momentum_negative="100"
image_negative_thumbnail_id_1="143"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0033.jpeg"
image_negative_thumbnail_id_2="1108"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0141.jpeg"
image_neutral_thumbnail_id_1="536"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0063.jpeg"
image_neutral_thumbnail_id_2="541"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0058.jpeg"
image_positive_thumbnail_id_1="629"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0079.jpeg"
image_positive_thumbnail_id_2="645"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0063.jpeg"
image_professor_thumbnail_id_1="1171"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0005.jpeg"
image_professor_thumbnail_id_2="1185"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0019.jpeg"
